The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of a first-in-human phase I dtudy of IMM01, SIRPα Fc protein in patients with relapsed or refractory lymphoma.
 
Mingyuan Sun
No Relationships to Disclose
 
Junyuan Qi
No Relationships to Disclose
 
Weiwei Zheng
No Relationships to Disclose
 
Lin Song
No Relationships to Disclose
 
Bo Jiang
No Relationships to Disclose
 
Zhenzhen Wang
No Relationships to Disclose
 
Cheng Huang
Employment - ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd.
 
Wenzhi Tian
Employment - ImmuneOnco Biopharmaceuticals
Leadership - ImmuneOnco Biopharmaceuticals
Stock and Other Ownership Interests - ImmuneOnco Biopharmaceuticals
 
Lugui Qiu
Consulting or Advisory Role - Amgen; BeiGene; Sanofi; Xian Jonshon
Speakers' Bureau - Amgen; BeiGene; Sanofi; Xian Jonshon